首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024
到
2008 2017 2018 2019 2020 2021 2022 2023 2024
检索 清除
手术分类
  • 全部（1880）
  • 腹部手术（323）
  • 胸科手术（41）
  • 血管手术（5）
  • 心脏手术（56）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（56）
  • 日间手术（26）
  • 手术室外（0）
  • 创伤和烧伤（0）
  • 非心脏手术（410）
  • 老年（0）
  • 小儿新生儿（126）
  • 特殊患者（42）
  • 未说明手术类型（678）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（43）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 2206 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2206.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with ACHD, it is recommended that intermediate- and high-risk elective surgery is performed in a centre with experience in the care of ACHD patients.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 建议ACHD患者至有相关经验的医疗中心行中-高风险NCS。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议ACHD患者至有相关经验的医疗中心行中-高风险NCS。（证据级别：C；推荐强度：I）

In patients with ACHD, it is recommended that intermediate- and high-risk elective surgery is performed in a centre with experience in the care of ACHD patients.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2207 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2207.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with acute pericarditis,deferring elective non-cardiac surgery（NCS） until complete resolution of the underlying process should be considered.(Evidence: Level C，Recommendation: Class IIa) [laiyuan] => 合并急性心包炎的患者，应考虑推迟择期NCS直至急性心包炎完全治愈。（证据级别：C；推荐强度：IIa） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
合并急性心包炎的患者，应考虑推迟择期NCS直至急性心包炎完全治愈。（证据级别：C；推荐强度：IIa）

In patients with acute pericarditis,deferring elective non-cardiac surgery（NCS） until complete resolution of the underlying process should be considered.(Evidence: Level C，Recommendation: Class IIa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2208 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2208.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Avoiding elective non-cardiac surgery（NCS） procedures under general anaesthesia until colchicine or the immunosuppressive treatment course for pericardial disease is completed may be considered.(Evidence: Level C ，Recommendation: Class IIb) [laiyuan] => 合并急性心包炎的患者在秋水仙碱或免疫抑制治疗疗程结束前，应避免择期全麻NCS。（证据级别：C；推荐强度：IIb） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
合并急性心包炎的患者在秋水仙碱或免疫抑制治疗疗程结束前，应避免择期全麻NCS。（证据级别：C；推荐强度：IIb）

Avoiding elective non-cardiac surgery（NCS） procedures under general anaesthesia until colchicine or the immunosuppressive treatment course for pericardial disease is completed may be considered.(Evidence: Level C ，Recommendation: Class IIb)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2209 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2209.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is recommended to continue chronic therapy for pulmonary arterial hypertension（PAH） in the perioperative phase of non-cardiac surgery（NCS）.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 建议合并PAH的患者行NCS，围术期不中断PAH治疗。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议合并PAH的患者行NCS，围术期不中断PAH治疗。（证据级别：C；推荐强度：I）

It is recommended to continue chronic therapy for pulmonary arterial hypertension（PAH） in the perioperative phase of non-cardiac surgery（NCS）.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2210 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2210.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is recommended that haemodynamic monitoring of patients with severe pulmonary arterial hypertension（PAH） continues for at least 24 h in the postoperative period.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 建议对重度PAH患者NCS术后行血流动力学监测至少24h。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议对重度PAH患者NCS术后行血流动力学监测至少24h。（证据级别：C；推荐强度：I）

It is recommended that haemodynamic monitoring of patients with severe pulmonary arterial hypertension（PAH） continues for at least 24 h in the postoperative period.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2211 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2211.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In the case of progression of right heart failure（HF） in the postoperative period in patients with pulmonary arterial hypertension（PAH）, it is recommended that the diuretic dose be optimized and, if necessary, i.v. prostacyclin analogues be initiated under the guidance of a physician experienced in the management of pulmonary arterial hypertension（PAH）.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 对合并PAH且NCS术后进展为急性右心衰的患者，建议调整利尿药剂量，必要时可在有PAH处理经验医师的指导下静脉使用前列环素类似物。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对合并PAH且NCS术后进展为急性右心衰的患者，建议调整利尿药剂量，必要时可在有PAH处理经验医师的指导下静脉使用前列环素类似物。（证据级别：C；推荐强度：I）

In the case of progression of right heart failure（HF） in the postoperative period in patients with pulmonary arterial hypertension（PAH）, it is recommended that the diuretic dose be optimized and, if necessary, i.v. prostacyclin analogues be initiated under the guidance of a physician experienced in the management of pulmonary arterial hypertension（PAH）.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2212 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2212.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Inodilator drugs (dobutamine,milrinone,levosimendan),which increase cardiac output and lower pulmonary vascular resistance,should be considered perioperatively according to the haemodynamic status of the patient.(Evidence: Level C，Recommendation: Class IIa) [laiyuan] => 根据患者血流动力学状态，可考虑使用正性肌力血管扩张药（如多巴酚丁胺、米力农、左西孟旦）增加心输出量（CO）、降低肺血管阻力。（证据级别：C；推荐强度：IIa） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
根据患者血流动力学状态，可考虑使用正性肌力血管扩张药（如多巴酚丁胺、米力农、左西孟旦）增加心输出量（CO）、降低肺血管阻力。（证据级别：C；推荐强度：IIa）

Inodilator drugs (dobutamine,milrinone,levosimendan),which increase cardiac output and lower pulmonary vascular resistance,should be considered perioperatively according to the haemodynamic status of the patient.(Evidence: Level C，Recommendation: Class IIa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2213 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2213.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with chronic hypertension undergoing elective NCS, it is recommended to avoid large peri-operative fluctuations in blood pressure, particularly hypotension, during theperi-operative period.(Evidence: Level A ，Recommendation: Class I) [laiyuan] => 对于患有慢性高血压且正在接受择期非心脏手术的患者，建议在围手术期避免血压出现较大的波动，尤其是低血压。（证据级别：A；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对于患有慢性高血压且正在接受择期非心脏手术的患者，建议在围手术期避免血压出现较大的波动，尤其是低血压。（证据级别：A；推荐强度：I）

In patients with chronic hypertension undergoing elective NCS, it is recommended to avoid large peri-operative fluctuations in blood pressure, particularly hypotension, during theperi-operative period.(Evidence: Level A ，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2214 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2214.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is recommended to perform pre-operative screening for hypertension-mediated organ damage and CV risk factors in newly diagnosed hypertensive patients who are scheduled for elective high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 建议对计划接受高风险非心脏手术的新诊断高血压患者进行术前筛查，以评估高血压导致的器官损伤和心血管风险因素。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议对计划接受高风险非心脏手术的新诊断高血压患者进行术前筛查，以评估高血压导致的器官损伤和心血管风险因素。（证据级别：C；推荐强度：I）

It is recommended to perform pre-operative screening for hypertension-mediated organ damage and CV risk factors in newly diagnosed hypertensive patients who are scheduled for elective high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2215 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2215.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is not recommended to defer NCS in patients with stage 1 or 2 hypertension.(Evidence: Level C，Recommendation: Class III) [laiyuan] => 对于1级或2级高血压患者，不建议推迟进行非心脏手术检查。（证据级别：C；推荐强度：III） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对于1级或2级高血压患者，不建议推迟进行非心脏手术检查。（证据级别：C；推荐强度：III）

It is not recommended to defer NCS in patients with stage 1 or 2 hypertension.(Evidence: Level C，Recommendation: Class III)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技